Vistagen Therapeutics VTGN SEC Filings

NASDAQ VTGN
$0.19 -0.01 (-5.00%)
At close: Nov 19, 2026 · 4:00 PM EST
EDGAR Disclosures

Latest SEC Filings

Latest filing SCHEDULE 13G ·
Source SEC EDGAR

Vistagen Therapeutics (VTGN) has filed 913 documents with the SEC since September 2007, all on EDGAR under CIK 1411685. In the last 12 months it filed 65, including 1 annual report (10-K), 3 quarterly reports (10-Q), 31 current reports (8-K) and 15 insider filings (Forms 3 and 4). The latest, a 5%+ passive stake (SCHEDULE 13G), was filed on Nov 16, 2026.

Form Type
# Form Type Description Accession Filed Filing Index
1SCHEDULE 13G5%+ passive stake0000921895-26-003193Nov 16, 2026 4:25 PM ET
2SCHEDULE 13G/A5%+ passive stake (amended)0001831942-26-000051Nov 16, 2026 11:10 AM ET-
310-QQuarterly report · quarter ended Sep 30, 20260001628280-26-073833Nov 13, 2026 11:11 AM ET
48-KCurrent report: earnings results0001628280-26-073824Nov 13, 2026 11:08 AM ET
58-KCurrent report: other events0001628280-26-071910Nov 9, 2026 8:34 AM ET
68-KCurrent report: exit or restructuring costs, other events0001628280-26-068627Oct 30, 2026 1:24 PM ET
78-KCurrent report: director or officer change0001628280-26-065559Oct 9, 2026 9:15 PM ET
88-KCurrent report: Reg FD disclosure0001628280-26-063510Sep 25, 2026 9:11 AM ET
98-KCurrent report: other events0001628280-26-063316Sep 24, 2026 7:05 AM ET
108-KCurrent report: other events0001628280-26-063046Sep 22, 2026 4:22 PM ET
118-KCurrent report: shareholder vote results0001628280-26-061445Sep 11, 2026 accepted Sep 10, 7:24 PM ET
12SCHEDULE 13G5%+ passive stake0000947871-26-000804Aug 14, 2026 5:49 PM ET
13SCHEDULE 13G5%+ passive stake0001193125-26-352371Aug 14, 2026 4:27 PM ET
1410-QQuarterly report · quarter ended Jun 30, 20260001628280-26-057116Aug 14, 2026 4:12 PM ET
15SCHEDULE 13G5%+ passive stake0001831942-26-000032Aug 14, 2026 4:04 PM ET
168-KCurrent report: earnings results0001628280-26-056953Aug 14, 2026 8:40 AM ET
178-KCurrent report: Reg FD disclosure, other events0001628280-26-054341Aug 6, 2026 4:16 PM ET
188-KCurrent report: listing standard notice0001628280-26-053304Aug 5, 2026 4:04 PM ET
19DEFA14AAdditional proxy materials0001628280-26-051406Jul 31, 2026 4:11 PM ET
20DEF 14AProxy statement0001628280-26-051404Jul 31, 2026 4:10 PM ET
214Insider transaction0001911501-26-000006Jul 31, 2026 8:56 AM ET
223Initial insider ownership0001911501-26-000004Jul 31, 2026 8:53 AM ET
238-KCurrent report: director or officer change, Reg FD disclosure0001628280-26-051251Jul 31, 2026 8:48 AM ET
244Insider transaction0001924908-26-000007Jul 2, 2026 4:34 PM ET
254Insider transaction0001794362-26-000004Jul 2, 2026 4:17 PM ET
264Insider transaction0001412071-26-000006Jul 2, 2026 4:16 PM ET
278-KCurrent report: Reg FD disclosure, other events0001628280-26-046143Jun 30, 2026 8:28 AM ET
288-KCurrent report: director or officer change0001628280-26-043989Jun 17, 2026 5:13 PM ET
2910-KAnnual report · fiscal year ended Mar 31, 20260001628280-26-043271Jun 15, 2026 4:50 PM ET
308-KCurrent report: earnings results0001628280-26-043232Jun 15, 2026 4:35 PM ET
318-KCurrent report: other events0001628280-26-041962Jun 9, 2026 5:04 PM ET
324Insider transaction0002132062-26-000004May 19, 2026 4:52 PM ET
333Initial insider ownership0002132062-26-000003May 19, 2026 4:51 PM ET
348-KCurrent report: director or officer change, Reg FD disclosure0001628280-26-036492May 19, 2026 4:30 PM ET
35SCHEDULE 13G5%+ passive stake0001193125-26-226886May 15, 2026 4:26 PM ET
368-KCurrent report: other events0001628280-26-033883May 12, 2026 7:44 AM ET
378-KCurrent report: other events0001628280-26-032935May 8, 2026 4:30 PM ET
388-KCurrent report: other events0001628280-26-027930Apr 28, 2026 4:13 PM ET
398-KCurrent report: director or officer change0001628280-26-024943Apr 13, 2026 5:27 PM ET
404Insider transaction0001794362-26-000002Apr 9, 2026 8:43 PM ET
414Insider transaction0001412071-26-000004Apr 9, 2026 8:41 PM ET
424Insider transaction0001998663-26-000006Apr 9, 2026 8:40 PM ET
434Insider transaction0002069951-26-000004Apr 9, 2026 8:38 PM ET
444Insider transaction0001924908-26-000005Apr 9, 2026 8:33 PM ET
458-KCurrent report: listing standard notice0001628280-26-023176Apr 2, 2026 4:16 PM ET
468-KCurrent report: director or officer change0001628280-26-019455Mar 18, 2026 4:45 PM ET
478-KCurrent report: Reg FD disclosure0001628280-26-018163Mar 16, 2026 4:10 PM ET
488-KCurrent report: other events0001628280-26-016652Mar 11, 2026 7:02 AM ET
498-KCurrent report: director or officer change0001628280-26-010035Feb 20, 2026 9:12 AM ET
50SCHEDULE 13G5%+ passive stake0000947871-26-000193Feb 17, 2026 6:33 PM ET
...

Vistagen Therapeutics SEC Filings API

Pull Vistagen Therapeutics's SEC filing index, with links to every filing and exhibit, into your own tools with the Business Quant SEC Filings API. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/secfilings?ticker=VTGN&formtype=10-K,10-Q&api_key=YOUR_API_KEY

Vistagen Therapeutics SEC filings: questions

What is Vistagen Therapeutics's CIK number?

Vistagen Therapeutics's Central Index Key (CIK) is 1411685, written 0001411685 in EDGAR's ten-digit form. The SEC files every Vistagen Therapeutics filing under this number.

When did Vistagen Therapeutics file its latest 10-K and 10-Q?

Its latest annual report, the 10-K for the fiscal year ended Mar 31, 2026, was filed on Jun 15, 2026; its latest quarterly report, the 10-Q for the quarter ended Sep 30, 2026, was filed on Nov 13, 2026.

How often does Vistagen Therapeutics file with the SEC?

Vistagen Therapeutics made 65 SEC filings in the last 12 months, most often 31 8-K filings, 12 Form 4 filings and 12 SCHEDULE 13G filings. The most recent, a 5%+ passive stake (SCHEDULE 13G), was filed on Nov 16, 2026.

Is there an API for Vistagen Therapeutics's SEC filings?

Yes. The Business Quant SEC Filings API returns Vistagen Therapeutics's filing index (913 filings), with links to every filing and exhibit on EDGAR: /secfilings?ticker=VTGN. Free API keys are available. SEC Filings API docs